In the third quarter, the production and operation of pharmaceutical machinery enterprises recovered well, and the profit growth rate exceeded double digits

On October 27, the National Bureau of Statistics released its monthly report on industrial economic benefits.
, industrial enterprises above the scale achieved profits of 436.65 billion yuan in the January-September period, down 2.4% year-on-year and 2.0 percentage points lower than in January-August, according to the data.
, third-quarter profit grew 15.9 percent, 11.1 percentage points faster than in the second quarter.
from different sectors of enterprises, the main industrial sector profits have maintained double-digit growth.
, the equipment manufacturing industry's third-quarter profit rose 22.5% year-on-year, driving the profits of industrial enterprises above the scale by 7.8 percentage points.
the third quarter, as market demand recovered and product prices rebounded, the upstream industry began to show a clear recovery trend.
, the recovery of downstream industries has a significant impact on upstream industry demand.
Pharmaceutical Equipment (Photo Source: Pharmaceutical Network) In fact, in terms of the pharmaceutical equipment industry in the equipment manufacturing sub-sector, most of the pharmaceutical companies that have disclosed their third-quarter reports reported significant third-quarter profit growth.
On October 28, Dongfulong officially released its third quarter 2020 report.
announced that revenue for the January-September period 2020 was RMB18.64, up 26.83 percent year-on-year, while net profit attributable to shareholders of listed companies was RMB288 million, up 375.33 percent year-on-year.
third quarter, the company reported a profit of 116 million yuan, up 418.27 percent from a year earlier.
It is learned that during the reporting period, the company focused on the "systematic, international, digital" development strategy, actively respond to customer needs, effectively guarantee the completion of the system project delivery plan;
Dongfulong is a global pharmaceutical companies to provide pharmaceutical technology, core equipment, systems engineering overall solutions of integrated pharmaceutical equipment service providers, the main business includes pharmaceutical equipment sector, medical technology and technology sector, food equipment engineering sector three major sectors.
Chutian Technology on October 24, Chutian Technology released its third-quarter 2020 report, and in January-September 2020, the company achieved operating income of RMB1.343 billion, up 1.71% YoY;
net profit attributable to shareholders of listed companies in the third quarter was RMB37,034.7 million, up 1053.83 percent year-on-year.
data show that Chutian Science and Technology's main business for pharmaceutical equipment research and development, design, production, sales and service.
Canaan Science and Technology Canaan Technology recently disclosed three-quarter report shows that the company in the first three quarters of 2019 achieved operating income of 359 million yuan, up 13.37 percent year-on-year, and the net profit attributable to shareholders of listed companies was 33.2537 million yuan, up 25.64 percent year-on-year.
, net profit attributable to shareholders of listed companies reached RMB15,079.2 million in the third quarter, up 50.28% YoY.
It is learned that Canaan Technology is a focus on solid preparation intelligent factory line equipment business pharmaceutical equipment enterprises, the main products include powder process equipment, solid preparation equipment, Chinese medicine extraction equipment, fluid process equipment and intelligent storage logistics system.
Xinlai Yingying on October 26, Xinlai Ying material released the third quarter of 2020 report, the announcement showed that in the third quarter of 2020, the company achieved revenue of 980 million yuan, a decrease of 1.52% YoY;
, net profit attributable to shareholders of listed companies in the third quarter was RMB28,907.9 million, an increase of 66.41 percent year-on-year. according to
data, Xinlai should be mainly engaged in high-purity stainless steel as the base material of high-clean application materials research and development, production and sales, the main products include vacuum systems, gas pipeline systems, pumps, valves, flanges, pipes and pipes, such as high-clean fluid piping systems and ultra-high vacuum systems of key components.
, the four pharmaceutical companies that have disclosed their third-quarter results have all seen year-on-year increases in net profit, all by more than double digits.
and in the first three quarters of 2020, most companies achieved good results.
is the reason behind it, although pharmaceutical equipment enterprises have been affected by the outbreak at the beginning of the year, but with the resumption of production, resumption of work smoothly, most of the company's production and operation has been restored, and with the recovery of the downstream pharmaceutical industry, the expansion of demand, the third quarter of the pharmaceutical equipment industry opportunities remain, continuing the good recovery situation in the second quarter.
industry expects the fourth quarter of pharmaceutical companies' performance to return to high growth.